NA Drug modeling software Market - Industry Trends and Forecast to 2030

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	214 Pages	Data Bridge Market Research	June, 2023	DAABD18055163

Best Price Guarantee
Price	from $3,500
Length	214 Pages
Publisher	Data Bridge Market Research
Published Date	June, 2023
SKU	DAABD18055163

NA Drug modeling software Market - Industry Trends and Forecast to 2030

The drug modeling software market is expected to reach USD 16,808.81 million by 2030 from USD 8,504.35 million in 2022, growing at a CAGR of 9.2% during the forecast period of 2023 to 2033.

Market Segmentation:
North America Drug Modeling Software Market, By Component (Software, and Services), Operating System (Windows, Linux, Mac OS, and Others), Deployment Mode (Cloud Based, Hybrid Based, and On Premises), Enterprise Size(Large Enterprise Size, Small and Medium Enterprise Size), Application (Graphical Molecular Modeling, Gene Sequence Analysis, Protein Modeling, Modeling Crystal Structures, Cheminformatics, High Throughput Virtual Screening, Gas and Solution Phase Reaction, Medical Imaging, and Others), Purchase Model (Subscription Based, and One- Time License), End User( Pharmaceutical and Biotechnology Companies, Contract Research Organization, Research Institutes, Regulatory Authorities, and Others), Country ( U.S., Canada, Mexico)- Industry Trends and Forecast to 2030

Overview of the Drug Modeling Software Market Dynamics:

Driver
• Rising drug discovery and development activities

Restrain

• Lack of quality data base

Opportunity

• Cloud computing and big data analytics in drug modelling

Market Players:

The key market players operating in the drug modeling software market are listed below:

• Dotmatics
• BC Platforms
• InSilicoTrials Technologies.
• VeriSIM Life., Atomwise Inc.
• Certara, USA.
• GENECODE
• Cresset., and Nanome Inc.
• SIMULATIONS PLUS.
• Dassault Systèmes
• Scripps Research
• XtalPi Inc.
• Xybion
• ArgusLab
• Schrödinger, Inc.

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of The North America Drug Modeling Software Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Multivariate Modeling; 2.7 Component Lifeline Curve; 2.8 Dbmr Market Position Grid; 2.9 Vendor Share Analysis; 2.10 Market Application Coverage Grid; 2.11 Secondary Sources; 2.12 Assumptions
3 Executive Summary: 3.1 Porter's Five Forces Model; 3.2 Value Chain Analysis; 3.3 Regulatory Standards; 3.4 Technological Trends; 3.5 Benefits Of Drug Modeling Software
4 Market Overview: 4.1 Drivers; 4.1.1 Rising Drug Discovery And Development Activities; 4.1.2 Rising Demand For Novel Therapies; 4.1.3 Precision Medicine And Intervention Of Ai In Drug Modelling; 4.2 Restraints; 4.2.1 Lack Of Quality Data Base; 4.2.2 High Cost Of Manufacturing Of Drug Modelling Software; 4.3 Opportunities; 4.3.1 Cloud Computing And Big Data Analytics In Drug Modelling; 4.3.2 Increasing Adoption Of Modelling Tools In Drug Discovery; 4.4 Challenges; 4.4.1 Lack Of Procedure For Multi-drug Effect Assesment; 4.4.2 Challenges With Model Interpretation
5 North America Drug Modeling Software Market, By Components: 5.1 Overview; 5.1.1 Software; 5.1.1.1 Integrated; 5.1.1.2 Standalone; 5.1.1.3 Ligand Based; 5.1.1.4 Structure Based; 5.2 Services; 5.2.1 Professional Services; 5.2.1.1 Consulting And Training; 5.2.1.2 Integration And Implementation; 5.2.1.3 Support And Maintenance; 5.2.2 Managed Services
6 North America Drug Modeling Software Market, By Operating System: 6.1 Overview; 6.2 Windows; 6.3 Linux; 6.4 Mac Os; 6.5 Others
7 North America Drug Modeling Software Market, By Deployment Mode: 7.1 Overview; 7.2 Cloud Based; 7.3 Hybrid-based; 7.4 On-premises
8 North America Drug Modeling Software Market, By Enterprise Size: 8.1 Overview; 8.2 Large Enterprise Size; 8.3 Small & Medium Enterprise Size
9 North America Drug Modeling Software Market, By Application: 9.1 Overview; 9.2 Graphical Molecular Modeling; 9.3 Gene Sequence Analysis; 9.4 Protein Modeling; 9.5 Modeling Crystal Structures; 9.6 Cheminformatics; 9.7 High Throughput Virtual Screening; 9.8 Gas & Solution Phase Reaction; 9.9 Medical Imaging; 9.10 Others
10 North America Drug Modeling Software Market, By Purchasing Model: 10.1 Overview; 10.2 Subscription Based; 10.2.1 Annually Subscription; 10.2.2 Monthly Subscription; 10.3 One-time License; 10.3.1 Group License; 10.3.2 Desktop License; 10.3.3 Others
11 North America Drug Modeling Software Market, By End User: 11.1 Overview; 11.2 Pharmaceutical & Biotechnology Companies; 11.2.1 Large Enterprise Size; 11.2.2 Small & Medium Enterprise Size; 11.3 Contract Research Organizations; 11.3.1 Large Enterprise Size; 11.3.2 Small & Medium Enterprise Size; 11.4 Research Institutes; 11.4.1 Large Enterprise Size; 11.4.2 Small & Medium Enterprise Size; 11.5 Regulatory Authorities; 11.5.1 Large Enterprise Size; 11.5.2 Small & Medium Enterprise Size; 11.6 Others; 11.6.1 Large Enterprise Size; 11.6.2 Small & Medium Enterprise Size
12 North America Drug Modeling Software Market, By Region: 12.1 North America; 12.1.1 U.S.; 12.1.2 Canada; 12.1.3 Mexico
13 North America Drug Modeling Software Market: Company Landscape: 13.1 Company Share Analysis: North America
14 Swot Analysis
15 North America Drug Modeling Software Market, Company Profile: 15.1 Dassault Systemes; 15.1.1 Company Snapshot; 15.1.2 Revenue Analysis; 15.1.3 Company Share Analysis; 15.1.4 Product Portfolio; 15.1.5 Recent Development; 15.2 Amazon Web Services, Inc. Or Its Affiliates.(A Subsidiary Of Amazon); 15.2.1 Company Snapshot; 15.2.2 Revenue Analysis; 15.2.3 Company Share Analysis; 15.2.4 Product Portfolio; 15.2.5 Recent Developments; 15.3 Certara, Usa.; 15.3.1 Company Snapshot; 15.3.2 Revenue Analysis; 15.3.3 Company Share Analysis; 15.3.4 Product Portfolio; 15.3.5 Recent Developments; 15.4 Schrödinger, Inc.; 15.4.1 Company Snapshot; 15.4.2 Revenue Analysis; 15.4.3 Company Share Analysis; 15.4.4 Product Portfolio; 15.4.5 Recent Development; 15.5 Cresset.; 15.5.1 Company Snapshot; 15.5.2 Company Share Analysis; 15.5.3 Product Portfolio; 15.5.4 Recent Developments; 15.6 Acellera Ltd; 15.6.1 Company Snapshot; 15.6.2 Product Portfolio; 15.6.3 Recent Developments; 15.7 Arguslab; 15.7.1 Company Snapshot; 15.7.2 Product Portfolio; 15.7.3 Recent Development; 15.8 Atomwise Inc.; 15.8.1 Company Snapshot; 15.8.2 Product Portfolio; 15.8.3 Recent Development; 15.9 Bc Platforms; 15.9.1 Company Snapshot; 15.9.2 Product Portfolio; 15.9.3 Recent Developments; 15.10 Biosolveit Gmbh; 15.10.1 Company Snapshot; 15.10.2 Product Portfolio; 15.10.3 Recent Development; 15.11 Dotmatics; 15.11.1 Company Snapshot; 15.11.2 Product Portfolio; 15.11.3 Recent Developments; 15.12 Genecode; 15.12.1 Company Snapshot; 15.12.2 Product Portfolio; 15.12.3 Recent Development; 15.13 Insilicotrials Technologies.; 15.13.1 Company Snapshot; 15.13.2 Product Portfolio; 15.13.3 Recent Developments; 15.14 Nanome Inc.; 15.14.1 Company Snapshot; 15.14.2 Product Portfolio; 15.14.3 Recent Development; 15.15 Optibrium, Ltd.; 15.15.1 Company Snapshot; 15.15.2 Product Portfolio; 15.15.3 Recent Development; 15.16 Pharmacelera; 15.16.1 Company Snapshot; 15.16.2 Product Portfolio; 15.16.3 Recent Development; 15.17 Simulations Plus.; 15.17.1 Company Snapshot; 15.17.2 Revenue Analysis; 15.17.3 Company Share Analysis; 15.17.4 Product Portfolio; 15.17.5 Recent Development; 15.18 The Scripps Research Institute; 15.18.1 Company Snapshot; 15.18.2 Product Portfolio; 15.18.3 Recent Development; 15.19 Verisim Life.; 15.19.1 Company Snapshot; 15.19.2 Product Portfolio; 15.19.3 Recent Developments; 15.20 Xtalpi Inc.; 15.20.1 Company Snapshot; 15.20.2 Product Portfolio; 15.20.3 Recent Development; 15.21 Xybion Digital Inc.; 15.21.1 Company Snapshot; 15.21.2 Revenue Analysis; 15.21.3 Product Portfolio; 15.21.4 Recent Development
16 Questionnaire
17 Related Reports
List Of Tables: Table 1 North America Drug Modeling Software Market, By Components, 2021-2030 (Usd Million); Table 2 North America Softaware In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 3 North America Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million); Table 4 North America Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 5 North America Services In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 6 North America Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 7 North America Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 8 North America Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million); Table 9 North America Windows In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 10 North America Linux In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 11 North America Mac Os In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 12 North America Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 13 North America Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million); Table 14 North America Cloud Based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 15 North America Hybrid-based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 16 North America On-premises In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 17 North America Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 18 North America Large Enterprise Size In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 19 North America Small & Medium Enterprise Size In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 20 North America Drug Modeling Software Market, By Application, 2021-2030 (Usd Million); Table 21 North America Graphical Molecular Modeling In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 22 North America Gene Sequence Analysis In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 23 North America Protein Modeling In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 24 North America Modeling Crystal Structures In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 25 North America Cheminformatics In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 26 North America High Throughput Virtual Screening In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 27 North America Gas & Solution Phase Reaction In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 28 North America Medical Imaging In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 29 North America Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 30 North America Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 31 North America Subscription Based In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 32 North America Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 33 North America One-time License In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 34 North America One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 35 North America Drug Modeling Software Market, By End User, 2021-2030 (Usd Million); Table 36 North America Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 37 North America Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 38 North America Contract Research Organizations In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 39 North America Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 40 North America Research Institutes In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 41 North America Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 42 North America Regulatory Authorities In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 43 North America Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 44 North America Others In Drug Modeling Software Market, By Region, 2021-2030 (Usd Million); Table 45 North America Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 46 North America Drug Modeling Software Market, By Country, 2021-2030 (Usd Million); Table 47 North America Drug Modeling Software Market, By Components, 2021-2030 (Usd Million); Table 48 North America Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million); Table 49 North America Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 50 North America Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 51 North America Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 52 North America Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million); Table 53 North America Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million); Table 54 North America Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 55 North America Drug Modeling Software Market, By Application, 2021-2030 (Usd Million); Table 56 North America Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 57 North America Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 58 North America One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 59 North America Drug Modeling Software Market, By End User, 2021-2030 (Usd Million); Table 60 North America Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 61 North America Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 62 North America Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 63 North America Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 64 North America Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 65 U.S. Drug Modeling Software Market, By Components, 2021-2030 (Usd Million); Table 66 U.S. Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million); Table 67 U.S. Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 68 U.S. Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 69 U.S. Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 70 U.S. Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million); Table 71 U.S. Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million); Table 72 U.S. Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 73 U.S. Drug Modeling Software Market, By Application, 2021-2030 (Usd Million); Table 74 U.S. Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 75 U.S. Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 76 U.S. One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 77 U.S. Drug Modeling Software Market, By End User, 2021-2030 (Usd Million); Table 78 U.S. Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 79 U.S. Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 80 U.S. Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 81 U.S. Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 82 U.S. Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 83 Canada Drug Modeling Software Market, By Components, 2021-2030 (Usd Million); Table 84 Canada Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million); Table 85 Canada Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 86 Canada Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 87 Canada Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 88 Canada Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million); Table 89 Canada Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million); Table 90 Canada Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 91 Canada Drug Modeling Software Market, By Application, 2021-2030 (Usd Million); Table 92 Canada Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 93 Canada Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 94 Canada One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 95 Canada Drug Modeling Software Market, By End User, 2021-2030 (Usd Million); Table 96 Canada Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 97 Canada Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 98 Canada Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 99 Canada Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 100 Canada Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 101 Mexico Drug Modeling Software Market, By Components, 2021-2030 (Usd Million); Table 102 Mexico Software In Drug Modeling Software Market, By Product Type, 2021-2030 (Usd Million); Table 103 Mexico Software In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 104 Mexico Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 105 Mexico Professional Services In Drug Modeling Software Market, By Type, 2021-2030 (Usd Million); Table 106 Mexico Drug Modeling Software Market, By Operating System, 2021-2030 (Usd Million); Table 107 Mexico Drug Modeling Software Market, By Deployment Mode, 2021-2030 (Usd Million); Table 108 Mexico Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 109 Mexico Drug Modeling Software Market, By Application, 2021-2030 (Usd Million); Table 110 Mexico Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 111 Mexico Subscription Based In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 112 Mexico One-time License In Drug Modeling Software Market, By Purchasing Model, 2021-2030 (Usd Million); Table 113 Mexico Drug Modeling Software Market, By End User, 2021-2030 (Usd Million); Table 114 Mexico Pharmaceutical & Biotechnology Companies In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 115 Mexico Contract Research Organizations In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 116 Mexico Research Institutes In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 117 Mexico Regulatory Authorities In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million); Table 118 Mexico Others In Drug Modeling Software Market, By Enterprise Size, 2021-2030 (Usd Million)
List Of Figures: Figure 1 North America Drug Modeling Software Market: Segmentation; Figure 2 North America Drug Modeling Software Market: Data Triangulation; Figure 3 North America Drug Modeling Software Market: Droc Analysis; Figure 4 North America Drug Modeling Software Market: North America Vs. Regional Market Analysis; Figure 5 North America Drug Modeling Software Market: Company Research Analysis; Figure 6 North America Drug Modeling Software Market: Interview Demographics; Figure 7 North America Drug Modeling Software Market: Multivariate Modeling; Figure 8 North America Drug Modeling Software Market: Dbmr Market Position Grid; Figure 9 North America Drug Modeling Software Market: Vendor Share Analysis; Figure 10 North America Drug Modeling Software Market: Market Application Coverage Grid; Figure 11 North America Drug Modeling Software Market: Segmentation; Figure 12 Rising Drug Discovery And Development Activities, Rising Demand For Novel Therapies, And Precision Medicine And Intervention Of Ai In Drug Modelling Are Are Expected To Drive The North America Drug Modeling Software Market Growth In The Forecast Period From 2023 To 2030; Figure 13 Software Segment Is Expected To Account For The Largest Share Of The North America Drug Modeling Software Market In 2023 & 2030; Figure 14 Drivers, Restraints, Opportunities, And Challenges Of The North America Drug Modeling Software Market; Figure 15 North America Drug Modeling Software Market: By Components, 2022; Figure 16 North America Drug Modeling Software Market: By Components, 2023-2030 (Usd Million); Figure 17 North America Drug Modeling Software Market: By Components, Cagr (2023-2030); Figure 18 North America Drug Modeling Software Market: By Components, Lifeline Curve; Figure 19 North America Drug Modeling Software Market: By Operating System, 2022; Figure 20 North America Drug Modeling Software Market: By Operating System, 2023-2030 (Usd Million); Figure 21 North America Drug Modeling Software Market: By Operating System, Cagr (2023-2030); Figure 22 North America Drug Modeling Software Market: By Operating System, Lifeline Curve; Figure 23 North America Drug Modeling Software Market: By Deployment Mode, 2022; Figure 24 North America Drug Modeling Software Market: By Deployment Mode, 2023-2030 (Usd Million); Figure 25 North America Drug Modeling Software Market: By Deployment Mode, Cagr (2023-2030); Figure 26 North America Drug Modeling Software Market: By Deployment Mode, Lifeline Curve; Figure 27 North America Drug Modeling Software Market: By Enterprise Size, 2022; Figure 28 North America Drug Modeling Software Market: By Enterprise Size, 2023-2030 (Usd Million); Figure 29 North America Drug Modeling Software Market: By Enterprise Size, Cagr (2023-2030); Figure 30 North America Drug Modeling Software Market: By Enterprise Size, Lifeline Curve; Figure 31 North America Drug Modeling Software Market: By Application, 2022; Figure 32 North America Drug Modeling Software Market: By Application, 2023-2030 (Usd Million); Figure 33 North America Drug Modeling Software Market: By Application, Cagr (2023-2030); Figure 34 North America Drug Modeling Software Market: By Application, Lifeline Curve; Figure 35 North America Drug Modeling Software Market: By Purchasing Model, 2022; Figure 36 North America Drug Modeling Software Market: By Purchasing Model, 2023-2030 (Usd Million); Figure 37 North America Drug Modeling Software Market: By Purchasing Model, Cagr (2023-2030); Figure 38 North America Drug Modeling Software Market: By Purchasing Model, Lifeline Curve; Figure 39 North America Drug Modeling Software Market: By End User, 2022; Figure 40 North America Drug Modeling Software Market: By End User, 2023-2030 (Usd Million); Figure 41 North America Drug Modeling Software Market: By End User, Cagr (2023-2030); Figure 42 North America Drug Modeling Software Market: By End User, Lifeline Curve; Figure 43 North America Drug Modeling Software Market: Snapshot (2022); Figure 44 North America Drug Modeling Software Market: By Country (2022); Figure 45 North America Drug Modeling Software Market: By Country (2023 & 2030); Figure 46 North America Drug Modeling Software Market: By Country (2022 & 2030); Figure 47 North America Drug Modeling Software Market: By Components (2023-2030); Figure 48 North America Drug Modeling Software Market: Company Share 2022 (%) 135